These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28179362)

  • 1. Photodynamic therapy for low risk prostate cancer.
    Ritch CR; Punnen S
    BMJ; 2017 Feb; 356():j575. PubMed ID: 28179362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review].
    Kleinclauss F; Frontczak A; Balssa L; Lebdai S; Azzouzi R
    Prog Urol; 2019; 29(8-9):393-401. PubMed ID: 31266699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
    BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?
    Moore CM; Hoh IM; Bown SG; Emberton M
    BJU Int; 2005 Oct; 96(6):754-8. PubMed ID: 16153193
    [No Abstract]   [Full Text] [Related]  

  • 5. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive treatment for localized prostate cancer.
    Porres D; Pfister D; Heidenreich A
    Minerva Urol Nefrol; 2012 Dec; 64(4):245-53. PubMed ID: 23288211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.
    Moore CM; Emberton M; Bown SG
    Lasers Surg Med; 2011 Sep; 43(7):768-75. PubMed ID: 22057504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: TOOKAD® soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Cadeddu JA
    J Urol; 2014 May; 191(5):1290. PubMed ID: 24745491
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: TOOKAD ® soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Taneja SS
    J Urol; 2014 Apr; 191(4):983-4. PubMed ID: 24703118
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.
    Haider MA; Davidson SR; Kale AV; Weersink RA; Evans AJ; Toi A; Gertner MR; Bogaards A; Wilson BC; Chin JL; Elhilali M; Trachtenberg J
    Radiology; 2007 Jul; 244(1):196-204. PubMed ID: 17507719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.
    Eggener SE; Coleman JA
    ScientificWorldJournal; 2008 Oct; 8():963-73. PubMed ID: 18836668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.
    Trachtenberg J; Weersink RA; Davidson SR; Haider MA; Bogaards A; Gertner MR; Evans A; Scherz A; Savard J; Chin JL; Wilson BC; Elhilali M
    BJU Int; 2008 Aug; 102(5):556-62. PubMed ID: 18494829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure.
    Azzouzi AR; Lebdai S; Benzaghou F; Stief C
    World J Urol; 2015 Jul; 33(7):937-44. PubMed ID: 25786708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell growth induced by photosensitizer PP(Arg)2-mediated photodynamic therapy in human breast and prostate cell lines. Part I.
    Nowak-Stępniowska A; Małecki M; Wiktorska K; Romiszewska A; Padzik-Graczyk A
    Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):39-48. PubMed ID: 21333933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.
    Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC
    Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Photodynamic therapy and prostate cancer].
    Colin P; Estevez JP; Betrouni N; Ouzzane A; Puech P; Leroy X; Biserte J; Villers A; Mordon S
    Prog Urol; 2011 Feb; 21(2):85-92. PubMed ID: 21296274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model.
    Bozzini G; Colin P; Betrouni N; Maurage CA; Leroy X; Simonin S; Martin-Schmitt C; Villers A; Mordon S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):296-303. PubMed ID: 23993856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryotherapy for prostate cancer: what we know, what we need to know.
    Theodorescu D
    J Urol; 2008 Aug; 180(2):437-8. PubMed ID: 18550127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.